Peiyao Li

4.4k citations
61 papers · 2.5k indexed · 1 hit paper · h-index 25
Topics
MicroRNA in disease regulation (16 papers)Cancer-related molecular mechanisms research (13 papers)Circular RNAs in diseases (11 papers)
Partner nations
ChinaUnited StatesUganda

In The Last Decade

Peiyao Li

57 papers receiving 2.5k citations

Hit Papers

CircRNA: functions and properties of a novel potential bi...201720262020202320172505007501000

Peers

Peiyao Li
Comparison fields: 5 of 114
  • Molecular Biology 2.2k
  • Cancer Research 1.7k
  • Immunology 199
  • Oncology 173
  • Epidemiology 110
Replace Hamish W. King with:
Hamish W. King United Kingdom
Christine Dolde United States
Lluís Morey United States
Manuela Quintavalle Italy
Inbal Wortzel Israel
Sònia Guil Spain
Russ P. Carstens United States
Sugiko Watanabe Japan
Keith M. Giles Australia
Kristy Reinert United States
Peiyao Li relative to Hamish W. King United Kingdom Hamish W. King's profile →
Citations per field
00.5×1.5×2.0×
Hamish W. King · 1×
Citations per year

Countries citing papers authored by Peiyao Li

Since Specialization
Citations

This map shows the geographic impact of Peiyao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiyao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiyao Li more than expected).

Fields of papers citing papers by Peiyao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiyao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiyao Li. The network helps show where Peiyao Li may publish in the future.

Co-authorship network of co-authors of Peiyao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Peiyao Li. A scholar is included among the top collaborators of Peiyao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiyao Li. Peiyao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 1
3 9
4 5
5 10
6 10
7 0
8 8
9 22
10 32
11 45
12 13
13 14
14 26
15 108
16 51
17 29
18 21
19 20
20 10

About Peiyao Li

Peiyao Li is a scholar working on Cancer Research, Cell Biology and Molecular Biology, having authored 61 papers that have together received 2.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (13 papers) and Circular RNAs in diseases (11 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (2.2k citations) and Immunology (199 citations). Peiyao Li has collaborated with scholars based in China, United States and Uganda. Frequent co-authors include Minghua Wu, Zihao Xu, Ziyang Feng, Ying Tang, Shujuan Meng, Changhong Liu, Minghua Wu, Li Fan, Zhibin Yu and Jianbo Feng. Their work appears in journals such as Nature Communications, Journal of Neuroscience and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026